Implementation of tranexamic acid for bleeding trauma patients: a longitudinal and cross-sectional study. (2019)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/emermed-2018-207693
PubMed Identifier: 30530744
Publication URI: http://europepmc.org/abstract/MED/30530744
Type: Journal Article/Review
Volume: 36
Parent Publication: Emergency medicine journal : EMJ
Issue: 2
ISSN: 1472-0205